Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
PC Group, Inc. (PCGR)
New York, NY, US
PC Group, Inc., through its subsidiaries, offers personal care products for the private label retail, medical, and therapeutic markets primarily in the United States, Canada, and Europe. Its personal care products include soaps, cleansers, toners, moisturizers, exfoliants, and facial masks, as well as over-the-counter drug products, such as acne soaps; and gel-based products, including gloves and sock products that are used for cosmetic and scar management purposes. The company’s gel-based orthopedic products include digitcare products, diabetes management products, products that protect the hands and wrists, gel sheeting products for various applications, and pressure, friction, and shear force absorption products, as well as products for the treatment of common orthopedic and footcare conditions; and gel-based prosthetic products for the treatment of common orthopedic and footcare conditions. PC Group sells its personal care products through account representatives to health and beauty companies, specialty retailers, cosmetics companies, direct marketing companies, amenities companies, health clubs and spas, and catalog companies; and medical products through national and regional account managers, field sales representatives, and inside sales representatives, as well as through medical distributors. The company was formerly known as Langer, Inc. and changed its name to PC Group, Inc. in July 2009 as a result of business focus shift to personal care products business. PC Group, Inc. was founded in 1971 and is headquartered in New York, New York.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | -98.00% | -97.50% | -100.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-06 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Specialties: +8.3%+10.1% ★ Q4'10: +20.5% (vs Q4'09)
-
EPS growth Medical - Specialties: +10.1%+84.0% ★ Q4'10: +110.6% (vs Q4'09)
-
FCF margin FCF growth · Medical - Specialties: +51.3%-1.8% Q4'10: -7.2% (vs Q4'09)
-
EBIT margin Medical - Specialties: +12.6%+2.8% Q4'10: +13.8% (vs Q4'09)
-
ROIC Medical - Specialties: +6.6%+14.5% ★ Q4'10: +66.1% (vs Q4'09)
-
Share dilution Medical - Specialties: 0.0%-2.3% ★ Q4'10: +0.0% (vs Q4'09)
-
Debt / EBITDA Net debt/EBITDA · Medical - Specialties: -0.39×0.73× Q4'10: 0.32× (vs Q4'09)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2009-12-31 | KANDERS WARREN B | Director / 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 1,706,856 | — | ↗ |
| 2009-09-30 | KANDERS WARREN B | Director / 10% Owner | X-InTheMoney | D | Warrants for Common Stock (right to buy) | 15,000 | 0.02 | 300.00 | 0 | — | ↗ |
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Peter A. Asch | President of Personal Care Products Division & Director | 294.0K | male |
| Karen Strebel | Administration Manager | — | female |
| Paul Langer | Vice President of Operations | — | male |
| Terence Fitzmaurice | Controller | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for PCGR
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
